TRAVELERS COMPANIES, INC. · Property and casualty insurance

TRV

Low riskNext report: Around Jan 20, 2027 (est.)

View price ↗

The short version

A high-quality, profitable business with steady sales. Institutions are adding.

Going well

Profitable every year for 10 years
Brings in more cash than it spends
Buying back shares: share count down 5.0% in 3 years

Money moves

Insiders sold $64.0M in the last 30 days
Institutions added 3.6% to their holdings in the quarter ending June 2026 (843 bought, 723 sold)
Held by Ray Dalio (Bridgewater)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$400.14+0.5% that day

Company value: $82.0B; Share price times all shares
Price vs profit (P/E): 10.5x; You pay about $11 for each $1 of yearly profit
Price vs sales: 1.7x; Company value is 1.7 times a year of sales
Cash vs value: 1%; Cash as a share of company value

From TRV's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Sep '26

$12.4B-0.5% vs a year earlier

Dec '23Tap a barSep '26

Last 12 months: $48.9B, up 1.1% from the 12 months before. Over 5 years, sales grew about 8.8% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of TRV. Starting points are the company's recent numbers.

Sales growth+1% a yearRecently: +1.1% a yearProfit margin17%Last 12 months: 17.0%P/E at the end11xToday: 10.5x. Many steady companies trade at 12x to 25xShare count change-2% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$51.4B

Profit in 5 years$8.7B

Price these guesses point to$519.01+30% vs $400.14 todayAbout +5.3% a year, before dividends

What today's price needs: with a 17% margin and a 11x P/E, sales could shrink about 4.1% a year for 5 years and still match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

5/5Strong

PassReturn on equity 15%+Earns a lot on the money owners have in the business.20.7%
PassNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.12.9%
PassProfitable every yearSteady profits, not one good year.10 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$10.6B
PassShare count not growingNot diluting owners. Falling means buybacks.-5.0% in 3 years

Revenue: $48.8B; +5.2% vs prior year
5-year growth: +8.8%/yr; revenue, per year
Free cash flow: $10.6B; 21.7% of revenue

From annual reports filed with the SEC. Gross margin doesn't apply to banks and insurers, so it isn't scored. Not in this company's SEC data, so not scored: debt under half of equity. A checklist is a starting point for research, not a verdict.

Latest quarter

Quarter ended Sep 30, 2026

Reported Oct 16Before open6:58 am ET

Revenue: $12.4B; -0.5% YoY
EPS: $9.04; vs $8.24
Free cash flow: $3.9B
Share count: -7.4%; vs a year ago

Insider rating

Last 90 days

18Heavy selling

6 insiders sold $64.0M (not pre-planned)

50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.

Weekly insider trend

13 weeks agoBoughtSoldThis week

Filing buzz

Last 7 days vs normal

83/ 100

This week: 11
Normal week: 2.2
vs normal: 4.9x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Accumulating+3.6%

Institutions added 3.6% to their holdings. 843 bought, 723 sold.

Shares held by institutions185.5M

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

-3.6%

Cash runwayAt last year's cash burn

Cash flow positive

Debt to equityLatest balance sheet: debt compared with what owners have

Total liabilities $113.1B

Shares outstandingLatest reported

205M

Earnings reports

Last 12

Next reportAround Jan 20, 2027 (est.)Estimated from the same quarter last year

Results filedOct 16
Results filedJul 17
Results filedApr 16
Results filedJan 21
Results filedOct 16, 2025

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

Offering prospectusJul 22 · View filing ↗Offering Offering prospectusJul 21 · View filing ↗Offering

Insider trades

Open-market buys and sells, last 90 days

Bought$00 insiders

Sold$64.0M6 insiders, 0 pre-planned

Insider	Trade	Shares	Avg price	Value	Owns after	Date
Jeffrey P. KlenkEVP & Pres., Bond & Spec. Ins.	Sell	9K	$405.57	$3.7M	6K	Oct 22Filing ↗
-59.7% of their holdings Not a pre-planned sale Filed 1 day after
David Donnay RowlandEVP & Co-Chief Invest. Officer	Sell	5K	$405.62	$2.0M	10K	Oct 22Filing ↗
-32.3% of their holdings Not a pre-planned sale Filed 1 day after
Gregory C ToczydlowskiEVP & President, Business Ins.	Sell	35K	$403.89	$14.0M	18K	Oct 22Filing ↗
-65.4% of their holdings $403.86 to $404.43 across 2 trades Not a pre-planned sale Filed 1 day after
Alan D SchnitzerChairman and CEO	Sell	89K	$396.77	$35.3M	303K	Oct 21Filing ↗
-22.7% of their holdings $394.80 to $398.21 across 5 trades Not a pre-planned sale Also Director Filed 2 days after
Maria OlivoEVP, ERM & Chief Risk Officer	Sell	15K	$398.44	$6.0M	104K	Oct 21Filing ↗
-12.7% of their holdings Not a pre-planned sale Filed 1 day after
Michael Frederick KleinEVP & President, Personal Ins.	Sell	8K	$392.79	$2.9M	45K	Oct 20Filing ↗
-14.3% of their holdings $392.69 to $393.26 across 2 trades Not a pre-planned sale Filed 2 days after